Long-term response to naltrexone in polycystic ovary syndrome? Reply of the authors

By Fruzzetti F.   Bersi C.   Parrini D.   Ricci C.   Genazzani A.R.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 659-660

Elsevier

Access to resources Recommend Favorite

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

By Fruzzetti F.   Bersi C.   Parrini D.   Ricci C.   Genazzani A.R.  

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 936-944

Elsevier

Access to resources Recommend Favorite

Insulin resistance and the long-term consequences of polycystic ovary syndrome

By Bhathena R. K.  

Journal of Obstetrics & Gynaecology, Vol. 31, Iss. 2, 2011-02 ,pp. : 105-110

Informa Healthcare

Access to resources Recommend Favorite

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

By The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 19-25

Elsevier

Access to resources Recommend Favorite

Polycystic ovary syndrome and metabolic syndrome

By Hayden Catherine J   Balen Adam H  

Expert Review of Obstretrics and Gynecology, Vol. 1, Iss. 2, 2006-11 ,pp. : 183-194

Informa Healthcare

Access to resources Recommend Favorite